Synthesis Capital (Boston) Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
27
- Exits
-
24
Synthesis Capital (Boston) General Information
Company Description
Founded in 2007, Synthesis Capital was a venture capital firm based in Boston, Massachusetts. The firm sought to invest in the life science, healthcare, biotechnology, biopharmaceutical, medical devices, medical technology, healthcare services, and novel drug development industries.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- 184 High Street
- 4th floor
- Boston, MA 02110
- United States
Synthesis Capital (Boston) Investments (27)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Triplebar | 25-Oct-2023 | Early Stage VC | Discovery Tools (Healthcare) | Generating Revenue | ||
| Trident Pharmaceuticals | 01-Sep-2012 | Biotechnology | Out of Business | |||
| Prexa Pharmaceuticals | 11-May-2011 | Pharmaceuticals | Out of Business | |||
| Horizon Pharmaceutical | 01-Jan-2011 | Drug Discovery | Generating Revenue | |||
| Nereus Pharmaceuticals | 23-Jun-2010 | Drug Discovery | Out of Business | |||
| Revision Therapeutics | 20-Apr-2010 | Drug Discovery | Out of Business | |||
| Ampla Pharmaceuticals | 28-Apr-2008 | Pharmaceuticals | Out of Business | |||
| CV Therapeutics | 16-Apr-2008 | Drug Discovery | Generating Revenue | |||
| Sirion Therapeutics | 09-Apr-2007 | Early Stage VC | Pharmaceuticals | Out of Business | ||
| Health Hero Networks | 17-Nov-2006 | Later Stage VC | Medical Records Systems | Generating Revenue |
Synthesis Capital (Boston) Exits (24)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| MedVantx | 01-Jan-2024 | Secondary Transaction - Private | |
| Horizon Pharmaceutical | 25-Oct-2016 | ||
| Trident Pharmaceuticals | 01-Nov-2015 | ||
| Prexa Pharmaceuticals | 01-May-2015 | ||
| Incanthera Therapeutics | 28-Jan-2015 | ||
| Revision Therapeutics | 01-Jan-2013 | ||
| Nereus Pharmaceuticals | 01-Dec-2012 | ||
| Astex Therapeutics | 20-Jul-2011 | ||
| Sirion Therapeutics | 08-Jun-2010 | Out of Business | |
| Decode Genetics | 15-Jan-2010 | Merger/Acquisition |
Synthesis Capital (Boston) Investments by Industry, Year, and Region
Synthesis Capital (Boston) Co-Investors (6)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Essential Capital | 1 |
|
|
||
| Rabo Investments |
|
|
|||
| Stray Dog Capital |
|
|
|||
| The Production Board |
|
|
|||
| iSelect Fund |
|
|
Synthesis Capital (Boston) FAQs
-
What is Synthesis Capital (Boston)?
Founded in 2007, Synthesis Capital was a venture capital firm based in Boston, Massachusetts.
-
When was Synthesis Capital (Boston) founded?
Synthesis Capital (Boston) was founded in 2007.
-
Where is Synthesis Capital (Boston) headquartered?
Synthesis Capital (Boston) is headquartered in Boston, MA.
-
How many investments has Synthesis Capital (Boston) made?
Synthesis Capital (Boston) has made 27 investments.
-
What has Synthesis Capital (Boston) invested in?
Synthesis Capital (Boston) has made numerous investments in companies like Triplebar, Trident Pharmaceuticals, and Prexa Pharmaceuticals within the Discovery Tools (Healthcare), Biotechnology, and Pharmaceuticals industries.
-
What has Synthesis Capital (Boston) invested in recently?
Synthesis Capital (Boston)'s latest investment was on 25-Oct-2023 in Triplebar, a company within the Discovery Tools (Healthcare) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process